Dr Reddys Laboratories Share Price Today - Live Blog for September 25, 2025

Dr Reddys Laboratories Ltd stock price decreased by -0.16%, with the current market value at ₹1,274.25 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.09% upswing, and it's currently trading at ₹1,275.25 per share. Investors are closely watching this development.

Dr Reddys Laboratories Ltd experienced a -0.12% downturn in its share price, and it's currently trading at ₹1,273.90. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd observed a remarkable 0.23% surge in its share price and is presently trading at ₹1,275.90. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd witnessed a substantial 0.05% increase in its share price and is currently trading at ₹1,274.80. This remarkable performance has caught the eye of investors.

After a notable 0.13% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,274.00. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's share price rallied by 0.05%, reaching the current market price of ₹1,272.25. This surge is indicative of the stock's recent positive performance.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.05%, signalling a challenging period. Currently trading at ₹1,271.00, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.11% boost, with the current market value at ₹1,270.50 per share. This surge has not gone unnoticed by investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.25%, presenting both challenges and opportunities for investors. As of now, it's trading at ₹1,269.55, and market participants are assessing the implications. The stock has a PE ratio of 19.0900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.03%, with its current market value per share resting at ₹1,272.90. This development highlights the stock's appeal to investors.

Dr Reddys Laboratories Ltd's share price has dropped by -0.44%, a development that warrants careful analysis. Presently trading at ₹1,272.35, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.02%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,277.65 per share.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.09% increase and currently trading at ₹1,277.25 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd's shares experienced a 0.09% uptick, and they are currently valued at ₹1,277.25, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd's share price has dropped by -0.31%, a development that warrants careful analysis. Presently trading at ₹1,276.00, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd witnessed a -0.14% decrease in its share price, and it is currently trading at ₹1,280.00. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 19.0900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.20%, reaching a current market price of ₹1,281.45. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd's share price has dropped by -0.00%, a development that warrants careful analysis. Presently trading at ₹1,284.00, investors are assessing whether this presents an opportunity or a risk.

Demonstrating a commendable 0.04% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,284.50. In terms of valuation, the stock maintains a PE ratio of 19.0900, while the industry PE ratio stands at 35.1946.

With a -0.22% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,284.20. This development raises questions about the factors behind the decline. The stock's PE ratio is 19.0900, while the industry PE is 35.1946.

With a -0.07% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,284.80. Investors should examine the factors driving this decline. The stock's PE ratio is 19.0900, whereas the industry PE ratio stands at 35.1946.

Dr Reddys Laboratories Ltd's shares experienced a 0.08% uptick, and they are currently valued at ₹1,285.90, making it an attractive choice for investors. The stock has a debt to equity ratio of 0.1394 and an ROE of 16.8559%.

Dr Reddys Laboratories Ltd observed a -0.34% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,286.00. The stock has a PE ratio of 19.0900, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd share price has declined by -0.15%, and it's currently trading at ₹1,293.00. The stock maintains a PE of 19.0900, while the industry PE is 35.1946, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.50%, signalling a challenging period. Currently trading at ₹1,293.95, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd stock price decreased by -0.40%, with the current market value at ₹1,300.40 per share. Investors are assessing the stock's potential for recovery and future growth prospects.